Australian sunscreen brands face stricter rules after safety scandal

The Therapeutic Goods Administration (TGA) announced a sweeping set of reforms for Australian sunscreen manufacturers on 27 October 2026, following a consumer‑driven safety scandal that exposed widespread discrepancies between labelled SPF values and actual protection levels. The new rules aim to restore consumer confidence by tightening testing protocols, mandating regular data submission, and clarifying the distinction between true UV‑protective sunscreens and cosmetic products that merely contain a secondary sun‑shielding function.

Background to the scandal

In June 2025, consumer advocacy group Choice published a damning report that examined twenty popular sunscreen products on the Australian market. Sixteen of those products – including several premium, higher‑priced brands – failed to meet the SPF rating claimed on their packaging. The investigation highlighted a systemic weakness in the existing regulatory framework, where manufacturers were not required to provide testing data to the TGA unless specifically asked.

The most striking case involved Ultra Violette’s Lean Screen Skinscreen, marketed with an “SPF 50+” label but found to deliver only SPF 4 in independent testing. The product’s voluntary recall last year, coupled with the broader finding that more than a dozen sunscreens were removed from shelves or had sales suspended, triggered a public outcry. Australians, living in a nation with the world’s highest skin‑cancer incidence, perceived the breach as a direct threat to public health.

Key elements of the proposed reforms

According to Robyn Langham, the TGA’s chief medical adviser, the reforms centre on “making SPF claims more reliable” and granting the agency “faster access to evidence when concerns arise.” The proposed measures introduce several concrete obligations for sunscreen suppliers. First, manufacturers must submit their SPF testing data to the TGA when a product is listed, a departure from the current practice where data submission is optional and only triggered by a regulator request.

Second, the TGA will require periodic re‑testing of finished products throughout their shelf life, ensuring that efficacy does not degrade over time. Third, the agency plans to limit the SPF claims that cosmetic sunscreen brands can make, thereby creating a clear market segmentation between products primarily designed for UV protection and those where sun protection is ancillary.

Implications for cosmetic versus therapeutic sunscreens

The distinction between “cosmetic” and “therapeutic” sunscreen products has long been blurred in Australia. Under the new rules, cosmetic brands will face caps on the SPF figures they can advertise, reflecting the regulator’s intent to prevent consumers from being misled by high‑SPF claims on products that are not primarily formulated for sun protection. This move seeks to provide a “clear distinction for consumers” between true UV‑blocking formulations and makeup‑type products that contain only a modest level of protection.

For manufacturers, the change means revisiting product positioning and marketing strategies. Brands that have historically marketed high‑SPF claims on cosmetic lines may need to reformulate or re‑brand to comply. Conversely, therapeutic sunscreen producers—those whose core function is UV protection—will be subject to more rigorous testing but retain the ability to advertise higher SPF values, provided they can substantiate those claims with robust data.

Regulatory enforcement and compliance timeline

The TGA indicated that the reforms will be “implemented in stages, with further consultation where required.” While the agency has not disclosed a precise rollout schedule, the staged approach suggests an initial focus on data submission and periodic testing, followed by the enforcement of SPF claim limits for cosmetic products. The regulator also signalled that labelling simplification and enhanced oversight of testing laboratories will be addressed after further review.

Manufacturers will need to adapt their quality‑assurance processes to accommodate regular testing throughout a product’s market life. This could involve establishing new partnerships with accredited laboratories, investing in internal testing capabilities, or adjusting production schedules to align with testing cycles. Failure to comply may result in product withdrawals, as seen in the recent scandal, or potential penalties under the TGA’s broader consumer‑protection mandate.

Industry reaction and consumer advocacy

Choice welcomed the TGA’s proposals, describing them as a “pleased to see” step toward stronger consumer protection. However, the group cautioned that the reforms fall short of full transparency. Choice argued that test results should not be confined to the regulator’s internal database but made publicly available and routinely monitored. The advocacy group emphasized that ongoing public scrutiny is essential to prevent a recurrence of the 2025 scandal.

Industry bodies have expressed mixed feelings. While many acknowledge the need to rebuild trust, some warn that the added compliance burden could increase product costs and potentially limit market entry for smaller firms lacking extensive testing infrastructure. The balance between safeguarding public health and maintaining a vibrant, competitive sunscreen market remains a point of contention.

Potential impact on Australian skin‑cancer rates

Australia’s status as a global skin‑cancer hotspot underscores the public health stakes of the sunscreen controversy. Robust SPF verification and clearer labelling are expected to improve the efficacy of sun‑protection practices among consumers. If the reforms lead to higher compliance and more accurate SPF information, they could contribute to better protection outcomes, especially during the summer months when UV exposure peaks.

Nevertheless, the reforms alone cannot address the broader behavioural factors that drive skin‑cancer incidence, such as outdoor work, recreational sun exposure, and cultural attitudes toward tanning. The TGA’s initiative should be viewed as a complementary measure alongside public‑health campaigns that promote regular sunscreen use, shade seeking, and skin checks.

Looking ahead: transparency and market confidence

The TGA’s proposed reforms represent a decisive regulatory response to a consumer‑driven crisis that exposed a gap between marketed claims and real‑world protection. By mandating data submission, periodic testing, and clearer SPF limits for cosmetic sunscreens, the agency aims to place “robust evidence” at the centre of sunscreen regulation, as articulated by Robyn Langham.

Future effectiveness will hinge on how rigorously the TGA enforces these rules and whether additional measures—such as public disclosure of test results—are adopted. As Choice has highlighted, transparency is a key component of public safety. If the regulator moves toward greater openness, it could further reinforce consumer confidence and set a benchmark for sunscreen oversight in other jurisdictions facing similar challenges.

This article was produced with AI-assisted research and editorial support. Reporting is based on the source material cited below. Sources: BBC News Asia; bbc.co.uk; Global1.News (29 October 2026).

By Kenji Tanaka, Staff Writer